Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological Intervention for Atrial Arrhythmias to Prevent New-Onset Atrial Fibrillation After TAVR
NCT07519161Phase 4Not yet recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2029
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of amiodarone, metoprolol in Atrial fibrillation (AFib), sponsored by Shanghai East Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
amiodaronemetoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07519161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519161.